Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 705Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

PHARMACOVIGILANCE PERSPECTIVES

Drug safety alerts of pharmacovigilance programme of India: A scope for targeted spontaneous reporting in India

Thota Prasad, Thota Anusha, Medhi Bikash, Sidhu Shabir, Kumar Pramod, Selvan V Kalai, Singh Gyanendra Nath

Year : 2018| Volume: 9| Issue : 1 | Page no: 51-55

   This article has been cited by
 
1 Study of adverse drug reactions to antiretroviral therapy in a tertiary care hospital, Tirupati
Rajalakshmi Rukmangathen,VasundaraDevi Brahmanapalli,DurgaPrasad Thammisetty,Deepishka Pemmasani,SaiDeepak Gali,RameshBabu Atmakuru
Perspectives in Clinical Research. 2019; 0(0): 0
[Pubmed]  [Google Scholar] [DOI]
2 Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India
Patrick K Moonan,Sreenivas A Nair,Reshu Agarwal,Vineet K Chadha,Puneet K Dewan,Umesh D Gupta,Christine S Ho,Timothy H Holtz,Ajay M Kumar,Nishant Kumar,Prahlad Kumar,Susan A Maloney,Sundari R Mase,John E Oeltmann,C N Paramasivan,Malik M Parmar,Kiran K Rade,Ranjani Ramachandran,Raghuram Rao,Virendra S Salhorta,Rohit Sarin,Sanjay Sarin,Kuldeep S Sachdeva,Sriram Selvaraju,Rupak Singla,Diya Surie,Jamhoih Tonsing,Srikanth P Tripathy,Sunil D Khaparde
BMJ Global Health. 2018; 3(5): e001135
[Pubmed]  [Google Scholar] [DOI]

 

Read this article